Mechanism of anthracycline-mediated down-regulation of GATA4 in the heart

Cardiovascular Research

Volumn 90, Issue 1, 2011, Pages 97-104

  Park, Ah Mee ^a   Nagase, Hiroko ^a   Liu, Lingling ^a   Vinod Kumar, Shilpashree ^a   Szwergold, Nava ^a   Wong, Chi Ming ^a   Suzuki, Yuichiro J ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anthracycline; Cardiotoxicity; GATA4; Heart; p53

Indexed keywords

CCAAT BINDING FACTOR; DAUNORUBICIN; PROTEIN P53; TRANSCRIPTION FACTOR GATA 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOWN REGULATION; GENE MAPPING; GENETIC TRANSCRIPTION; HEART; HEART MUSCLE CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BASE SEQUENCE; BENZOTHIAZOLES; BINDING SITES; CCAAT-BINDING FACTOR; CELL LINE; DAUNORUBICIN; DOWN-REGULATION; GATA4 TRANSCRIPTION FACTOR; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; PERFUSION; PROMOTER REGIONS, GENETIC; TIME FACTORS; TOLUENE; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952833333     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq361     Document Type: Article

References (30)

1. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. New Engl J Med 1998; 339:900-905. (Pubitemid 28446849)
2. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000;60: 1789-1792. (Pubitemid 30207630)
3. Kang YJ, Zhou ZX, Wang GW, Buridi A, Klein JB. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogenactivated protein kinases. J Biol Chem 2000;275:13690-13698. (Pubitemid 30257439)
4. Suzuki YJ, Evans T. Regulation of cardiac myocyte apoptosis by the GATA-4 transcription factor. Life Sci 2004;74:1829-1838. (Pubitemid 38167552)
5. Kim Y, Ma AG, Kitta K, Fitch SN, Ikeda T, Ihara Y et al. Anthracycline-induced suppression of GATA-4 transcription factor: implication in the regulation of cardiac myocyte apoptosis. Mol Pharmacol 2003;63:368-377. (Pubitemid 36158372)
6. Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc Natl Acad Sci USA 2004;101: 6975-6980. (Pubitemid 38596428)
7. Kitta K, Day RM, Kim Y, Torregroza I, Evans T, Suzuki YJ. Hepatocyte growth factor induces GATA-4 phosphorylation and cell survival in cardiac muscle cells. J Biol Chem 2003;278:4705-4712. (Pubitemid 36800970)
8. Kobayashi S, Lackey T, Huang Y, Bisping E, Pu WT, Boxer LM et al. Transcription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB J 2006;20:800-802. (Pubitemid 46671220)
9. Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, Walsh K et al. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation 2001;103:555-651.
10. Nagase H, Vinod Kumar S, Szwergold NR, Day RM, Suzuki YJ. Characterizations of the cardiac GATA-4 promoter. Proc Am Thorac Soc 2006;3:A686(abstract).
11. Ohara Y, Atarashi T, Ishibashi T, Ohashi-Kobayashi A, Maeda M. GATA-4 gene organization and analysis of its promoter. Biol Pharm Bull 2006;29:410-419.
12. Park AM, Nagase H, Vinod Kumar S, Suzuki YJ. Acute intermittent hypoxia activates myocardial cell survival signaling. Am J Physiol 2007;292:H751-H757.
13. Claycomb WC, Lanson NA, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci USA 1998;95:2979-2984. (Pubitemid 28135840)
14. Kitta K, Clément SA, Remeika J, Blumberg JB, Suzuki YJ. Endothelin-1 induces phosphorylation of GATA-4 transcription factor in HL-1 atrial-muscle cell line. Biochem J 2001;359:375-380. (Pubitemid 32999782)
15. Park AM, Suzuki YJ. Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J Appl Physiol 2007;102:1806-1814. (Pubitemid 46701948)
16. Wong CM, Cheema AK, Zhang L, Suzuki YJ. Protein carbonylation as a novel mechanism in redox signaling. Circ Res 2008;102:310-318. (Pubitemid 351271651)
17. Park AM, Nagase H, Vinod Kumar SV, Suzuki YJ. Effects of intermittent hypoxia on the heart. Antioxid Redox Signal 2007;9:723-729. (Pubitemid 46799104)
18. Park AM, Wong CM, Jelinkova L, Liu L, Nagase H, Suzuki YJ. Pulmonary hypertension-induced GATA4 activation in the right ventricle. Hypertension 2010; 56:1145-1151.
19. L'Ecuyer T, Sanjeev S, Thomas R, Novak R, Das L, Campbell Wet al. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. Am J Physiol 2006;291: H1273-H1280. (Pubitemid 44343672)
20. Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice. Mol Cell Biochem 2005;273: 25-32. (Pubitemid 40774760)
21. Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M et al. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nature Cell Biol 2007;9:1175-1183. (Pubitemid 47500494)
22. Nithipongvanitch R, Ittarat W, Cole MP, Tangpong J, St. Clair DK, Oberley TD. Mitochondrial and nuclear p53 localization in cardiomyocytes: redox modulation by doxorubicin (adriamycin)? Free Radic Biol Med 2007;9:1001-1008. (Pubitemid 46919601)
23. Komarov PG, Komarova EA, Kondratov RV, Christov-Tselkov K, Coon JS, Chernov MV et al. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999;285:1733-1737. (Pubitemid 29428873)
24. Nerlov C. The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007;17:318-324. (Pubitemid 47102200)
25. Mantovani R. The molecular biology of the CCAAT-binding factor NF-Y. Gene 1999; 239:15-27. (Pubitemid 29462565)
26. Bhattacharya A, Deng JM, Zhang Z, Behringer R, de Crombrugghe B, Maity SN. The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation. Cancer Res 2003;63: 8167-8172. (Pubitemid 37549464)
27. Jung MS, Yun J, Chae HD, Kim JM, Kim SC, Choi TS et al. p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 2001;20:5818-5825. (Pubitemid 32937951)
28. Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR et al. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 2006;103:14471-14476. (Pubitemid 44484774)
29. Oka T, Maillet M, Watt AJ, Schwartz RJ, Aronow BJ, Duncan SA et al. Cardiac-specific deletion of Gata4 reveals its requirement for hypertrophy, compensation, and myocyte viability. Circ Res 2006;98:837-845.
30. Sano M, Minamino T, Toko H, Miyauchi H, Orimo M, Qin Y et al. p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload. Nature 2007;446: 444-448. (Pubitemid 46474597)